Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization
- PMID: 9973190
Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization
Abstract
We used comparative genomic hybridization to study malignant fibrous histiocytomas (MFHs) from 19 patients to detect changes in the copy number of DNA sequences, along entire chromosomes. Together with losses and gains in various chromosomal regions, distinct high-level amplifications were found at six loci (4q12-21, 8p21-pter, 8q24.1-qter, 9q12-13, 12p11.2-pter, and 15q11.2-15), suggesting that those regions may contain unknown (proto) oncogenes. We focused on the 8p amplicon, where detailed characterization allowed us to determine that the minimal common amplified region lay between markers D8S1819 and D8S550 at 8p23.1. A novel gene designated MASL1 (MFH-amplified sequences with leucine-rich tandem repeats 1) was isolated from within this narrowly defined region. Expression of the MASL1 gene was enhanced significantly in MFH tumors bearing the 8p amplicon. The primary structure of its deduced product revealed an ATP/GTP-binding site, three leucine zipper domains, and a leucine-rich tandem repeat, all of which are important structural or functional elements for interactions among proteins related to the cell cycle. These features suggest that overexpression of MASL1 might well be oncogenic with respect to MFH.
Similar articles
-
Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.Cancer Genet Cytogenet. 2004 Apr 1;150(1):27-32. doi: 10.1016/j.cancergencyto.2003.08.009. Cancer Genet Cytogenet. 2004. PMID: 15041220
-
Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.Am J Pathol. 1997 Oct;151(4):1153-61. Am J Pathol. 1997. PMID: 9327749 Free PMC article.
-
MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.Oncogene. 2004 Apr 1;23(14):2576-81. doi: 10.1038/sj.onc.1207352. Oncogene. 2004. PMID: 14691450
-
MASL1: a neglected ROCO protein.Biochem Soc Trans. 2012 Oct;40(5):1090-4. doi: 10.1042/BST20120127. Biochem Soc Trans. 2012. PMID: 22988871 Review.
-
Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.Acta Pharmacol Sin. 2010 Sep;31(9):1165-71. doi: 10.1038/aps.2010.94. Epub 2010 Aug 2. Acta Pharmacol Sin. 2010. PMID: 20676120 Free PMC article. Review.
Cited by
-
MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.Oncotarget. 2016 Nov 29;7(48):78726-78735. doi: 10.18632/oncotarget.12807. Oncotarget. 2016. PMID: 27783989 Free PMC article.
-
Genetic, structural, and molecular insights into the function of ras of complex proteins domains.Chem Biol. 2014 Jul 17;21(7):809-18. doi: 10.1016/j.chembiol.2014.05.010. Epub 2014 Jun 26. Chem Biol. 2014. PMID: 24981771 Free PMC article. Review.
-
Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.Front Genet. 2023 Feb 16;14:1109491. doi: 10.3389/fgene.2023.1109491. eCollection 2023. Front Genet. 2023. PMID: 36873946 Free PMC article. Review.
-
Role and mechanism of action of leucine-rich repeat kinase 1 in bone.Bone Res. 2017 Mar 14;5:17003. doi: 10.1038/boneres.2017.3. eCollection 2017. Bone Res. 2017. PMID: 28326224 Free PMC article. Review.
-
Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas.Jpn J Cancer Res. 2000 Feb;91(2):156-63. doi: 10.1111/j.1349-7006.2000.tb00927.x. Jpn J Cancer Res. 2000. PMID: 10761702 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases